181 related articles for article (PubMed ID: 8031035)
1. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.
Shaw T; Amor P; Civitico G; Boyd M; Locarnini S
Antimicrob Agents Chemother; 1994 Apr; 38(4):719-23. PubMed ID: 8031035
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro.
Colledge D; Locarnini S; Shaw T
Hepatology; 1997 Jul; 26(1):216-25. PubMed ID: 9214473
[TBL] [Abstract][Full Text] [Related]
4. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
Colledge D; Civitico G; Locarnini S; Shaw T
Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
[TBL] [Abstract][Full Text] [Related]
5. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.
Lin E; Luscombe C; Colledge D; Wang YY; Locarnini S
Antimicrob Agents Chemother; 1998 Aug; 42(8):2132-7. PubMed ID: 9687423
[TBL] [Abstract][Full Text] [Related]
6. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
[TBL] [Abstract][Full Text] [Related]
7. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
[TBL] [Abstract][Full Text] [Related]
8. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
Civitico G; Wang YY; Luscombe C; Bishop N; Tachedjian G; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):90-7. PubMed ID: 1696959
[TBL] [Abstract][Full Text] [Related]
9. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
[TBL] [Abstract][Full Text] [Related]
10. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
Tsiquaye KN; Slomka MJ; Maung M
J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
[TBL] [Abstract][Full Text] [Related]
11. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
[TBL] [Abstract][Full Text] [Related]
12. Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro.
Civitico G; Shaw T; Locarnini S
Antimicrob Agents Chemother; 1996 May; 40(5):1180-5. PubMed ID: 8723462
[TBL] [Abstract][Full Text] [Related]
13. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
Luscombe C; Pedersen J; Uren E; Locarnini S
Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
[TBL] [Abstract][Full Text] [Related]
14. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
Fourel I; Saputelli J; Schaffer P; Mason WS
J Virol; 1994 Feb; 68(2):1059-65. PubMed ID: 8289335
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
[TBL] [Abstract][Full Text] [Related]
16. Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture.
Hung LF; Brumbaugh AE; Bhatia G; Marion PL; Hung PP; Norbeck DW; Plattner JJ; Robinson WS
J Med Virol; 1991 Nov; 35(3):180-6. PubMed ID: 1804929
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
Schröder I; Holmgren B; Oberg M; Löfgren B
Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
[TBL] [Abstract][Full Text] [Related]
18. The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.
Niu J; Wang Y; Dixon R; Bowden S; Qiao M; Einck L; Locarnini S
Antiviral Res; 1993 Jun; 21(2):155-71. PubMed ID: 7687840
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.
Nicoll AJ; Colledge DL; Toole JJ; Angus PW; Smallwood RA; Locarnini SA
Antimicrob Agents Chemother; 1998 Dec; 42(12):3130-5. PubMed ID: 9835503
[TBL] [Abstract][Full Text] [Related]
20. Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir.
Dean J; Bowden S; Locarnini S
Antiviral Res; 1995 May; 27(1-2):171-8. PubMed ID: 7486954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]